Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2862442 | 0.95 | ALDH1A1 (0.60) | KMT2AALDH1A1LMNAMEN1CHRM2 | |
| SCHEMBL18608789 | 0.93 | MEN1 (0.58) | KMT2AMEN1CHRM2CHRM4CHRM1 | |
| SCHEMBL20274773 | 0.90 | TP53 (0.50) | KMT2AMEN1CHRM4TP53THRB | |
| SCHEMBL3863834 | 0.90 | KMT2A (0.63) | KMT2AALDH1A1LMNAMEN1TP53 | |
| SCHEMBL17624335 | 0.89 | CYP2D6 (0.47) | KMT2AALDH1A1LMNAMEN1CHRM2 | |
| SCHEMBL7618720 | 0.88 | HRH3 (0.61) | KMT2AMEN1CHRM2CHRM4CHRM1 | |
| SCHEMBL13077750 | 0.88 | MEN1 (0.53) | KMT2AMEN1CHRM2CHRM4CHRM1 | |
| SCHEMBL13388551 | 0.88 | L3MBTL1 (0.54) | KMT2ALMNAMEN1TP53MAPT | |
| SCHEMBL13925211 | 0.88 | CD4 (0.47) | KMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL7612330 | 0.87 | MEN1 (0.52) | KMT2AMEN1CHRM2CHRM4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076625-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |
| EP-2049529-B1 | SUBSTITUTED DIAZEPAN OREXIN RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME (US) | 2010-08-11 | — | — | EP | disclosed |
| WO-2008008518-A1 | SUBSTITUTED DIAZEPAN OREXIN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2008-01-17 | — | — | WO | disclosed |